183 related articles for article (PubMed ID: 11550792)
21. Aptamers targeting RNA molecules.
Watrin M; Dausse E; Lebars I; Rayner B; Bugaut A; Toulmé JJ
Methods Mol Biol; 2009; 535():79-105. PubMed ID: 19377979
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region.
Vickers TA; Ecker DJ
Nucleic Acids Res; 1992 Aug; 20(15):3945-53. PubMed ID: 1508680
[TBL] [Abstract][Full Text] [Related]
23. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
Churcher MJ; Lowe AD; Gait MJ; Karn J
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
[TBL] [Abstract][Full Text] [Related]
24. Driving in vitro selection of anti-HIV-1 TAR aptamers by magnesium concentration and temperature.
Darfeuille F; Sekkai D; Dausse E; Kolb G; Yurchenko L; Boiziau C; Toulmé JJ
Comb Chem High Throughput Screen; 2002 Jun; 5(4):313-25. PubMed ID: 12052182
[TBL] [Abstract][Full Text] [Related]
25. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
Watrin M; Von Pelchrzim F; Dausse E; Schroeder R; Toulmé JJ
Biochemistry; 2009 Jul; 48(26):6278-84. PubMed ID: 19496624
[TBL] [Abstract][Full Text] [Related]
26. The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.
Berkhout B; van Wamel JL
RNA; 2000 Feb; 6(2):282-95. PubMed ID: 10688366
[TBL] [Abstract][Full Text] [Related]
27. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
Kolb G; Reigadas S; Boiziau C; van Aerschot A; Arzumanov A; Gait MJ; Herdewijn P; Toulmé JJ
Biochemistry; 2005 Mar; 44(8):2926-33. PubMed ID: 15723535
[TBL] [Abstract][Full Text] [Related]
28. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
[TBL] [Abstract][Full Text] [Related]
29. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
30. Dual-specificity interaction of HIV-1 TAR RNA with Tat peptide-oligonucleotide conjugates.
Tung CH; Wang J; Leibowitz MJ; Stein S
Bioconjug Chem; 1995; 6(3):292-5. PubMed ID: 7632801
[TBL] [Abstract][Full Text] [Related]
31. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
32. Identification of aptamers against the DNA template for in vitro transcription of the HIV-1 TAR element.
Boiziau C; Dausse E; Mishra R; Ducongé F; Toulmé JJ
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):369-80. PubMed ID: 9303189
[TBL] [Abstract][Full Text] [Related]
33. Pseudo--half-knot formation with RNA.
Ecker DJ; Vickers TA; Bruice TW; Freier SM; Jenison RD; Manoharan M; Zounes M
Science; 1992 Aug; 257(5072):958-61. PubMed ID: 1502560
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
35. Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA.
Boutimah-Hamoudi F; Leforestier E; Sénamaud-Beaufort C; Nielsen PE; Giovannangeli C; Saison-Behmoaras TE
Nucleic Acids Res; 2007; 35(12):3907-17. PubMed ID: 17537815
[TBL] [Abstract][Full Text] [Related]
36. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
[TBL] [Abstract][Full Text] [Related]
37. HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements.
Reyes-Darias JA; Sánchez-Luque FJ; Berzal-Herranz A
Virus Res; 2012 Oct; 169(1):63-71. PubMed ID: 22820401
[TBL] [Abstract][Full Text] [Related]
38. The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.
Volkmann S; Dannull J; Moelling K
Biochimie; 1993; 75(1-2):71-8. PubMed ID: 7684936
[TBL] [Abstract][Full Text] [Related]
39. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate.
Hamma T; Saleh A; Huq I; Rana TM; Miller PS
Bioorg Med Chem Lett; 2003 Jun; 13(11):1845-8. PubMed ID: 12749881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
